Literature DB >> 30334694

Triple CFTR Modulator Therapy for Cystic Fibrosis.

Fernando Holguin1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30334694     DOI： 10.1056/NEJMe1811996

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

1.  Discovery of ABBV/GLPG-3221, a Potent Corrector of CFTR for the Treatment of Cystic Fibrosis.

Authors:  Marc J C Scanio; Xenia B Searle; Bo Liu; John R Koenig; Robert Altenbach; Gregory A Gfesser; Andrew Bogdan; Stephen Greszler; Gang Zhao; Ashvani Singh; Yihong Fan; Andrew M Swensen; Timothy Vortherms; Arlene Manelli; Corina Balut; Ying Jia; Wenqing Gao; Hong Yong; Michael Schrimpf; Chris Tse; Philip Kym; Xueqing Wang
Journal:  ACS Med Chem Lett       Date:  2019-10-31       Impact factor: 4.345

2.  Genetic Variation Near chrXq22-q23 Is Linked to Emotional Functioning in Cystic Fibrosis.

Authors:  Eric Barbato; Barbara Daly; Sara Douglas; Mary Kerr; Paul Litman; Rebecca Darrah
Journal:  Biol Res Nurs       Date:  2020-05-11       Impact factor: 2.522

Review 3.  Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapy: A Review for the Otolaryngologist.

Authors:  Saangyoung E Lee; Zainab Farzal; M Leigh Anne Daniels; Brian D Thorp; Adam M Zanation; Brent A Senior; Charles S Ebert; Adam J Kimple
Journal:  Am J Rhinol Allergy       Date:  2020-03-13       Impact factor: 2.467

Review 4.  A Review of Trikafta: Triple Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulator Therapy.

Authors:  Anas Zaher; Jude ElSaygh; Dalal Elsori; Hassan ElSaygh; Abdulsabar Sanni
Journal:  Cureus       Date:  2021-07-03

5.  Changes in fecal microbiota with CFTR modulator therapy: A pilot study.

Authors:  C E Pope; A T Vo; H S Hayden; E J Weiss; S Durfey; S McNamara; A Ratjen; B Grogan; S Carter; L Nay; M R Parsek; P K Singh; E F McKone; M L Aitken; M R Rosenfeld; L R Hoffman
Journal:  J Cyst Fibros       Date:  2020-12-31       Impact factor: 5.527

Review 6.  Exercise Physiology Across the Lifespan in Cystic Fibrosis.

Authors:  Ren-Jay Shei; Kelly A Mackintosh; Jacelyn E Peabody Lever; Melitta A McNarry; Stefanie Krick
Journal:  Front Physiol       Date:  2019-11-05       Impact factor: 4.566

7.  Fluorescence assay for simultaneous quantification of CFTR ion-channel function and plasma membrane proximity.

Authors:  Stella Prins; Emily Langron; Cato Hastings; Emily J Hill; Andra C Stefan; Lewis D Griffin; Paola Vergani
Journal:  J Biol Chem       Date:  2020-09-15       Impact factor: 5.157

8.  Computed Tomographic Changes in Patients with Cystic Fibrosis Treated by Combination Therapy with Lumacaftor and Ivacaftor.

Authors:  François Arnaud; Nathalie Stremler-Le Bel; Martine Reynaud-Gaubert; Julien Mancini; Jean-Yves Gaubert; Guillaume Gorincour
Journal:  J Clin Med       Date:  2021-05-07       Impact factor: 4.241
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.